G

Guobang Pharma Ltd
SSE:605507

Watchlist Manager
Guobang Pharma Ltd
SSE:605507
Watchlist
Price: 20.48 CNY -0.15% Market Closed
Market Cap: 11.4B CNY
Have any thoughts about
Guobang Pharma Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Guobang Pharma Ltd

Current Assets 5.1B
Cash & Short-Term Investments 1.6B
Receivables 1.3B
Other Current Assets 2.2B
Non-Current Assets 5B
Long-Term Investments 194.2m
PP&E 4.4B
Intangibles 354.7m
Other Non-Current Assets 17.7m
Current Liabilities 2.3B
Accounts Payable 622m
Accrued Liabilities 89.8m
Short-Term Debt 1B
Other Current Liabilities 502.6m
Non-Current Liabilities 256.1m
Long-Term Debt 230m
Other Non-Current Liabilities 26.1m

Balance Sheet
Guobang Pharma Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
691
783
879
574
1 581
1 701
Cash
691
783
879
574
1 581
1 701
Short-Term Investments
304
150
0
1 258
825
466
Total Receivables
648
593
594
656
848
1 022
Accounts Receivables
364
377
385
445
667
532
Other Receivables
284
216
209
211
181
490
Inventory
869
847
990
1 309
1 409
1 369
Other Current Assets
320
388
409
770
466
885
Total Current Assets
2 832
2 760
2 871
4 567
5 129
5 443
PP&E Net
1 216
1 690
2 337
2 635
3 347
4 347
PP&E Gross
1 216
1 690
2 337
2 635
3 347
4 347
Accumulated Depreciation
560
679
818
987
1 162
1 448
Intangible Assets
156
275
267
272
370
359
Goodwill
0
0
0
0
0
0
Note Receivable
141
0
0
0
0
0
Long-Term Investments
0
20
19
17
181
197
Other Long-Term Assets
22
14
15
22
16
16
Other Assets
0
0
0
0
0
0
Total Assets
4 367
N/A
4 759
+9%
5 509
+16%
7 513
+36%
9 043
+20%
10 362
+15%
Liabilities
Accounts Payable
321
433
441
357
432
624
Accrued Liabilities
83
72
90
104
111
102
Short-Term Debt
1 157
845
1 173
601
1 207
1 580
Current Portion of Long-Term Debt
0
0
150
0
0
29
Other Current Liabilities
154
224
119
91
113
116
Total Current Liabilities
1 716
1 574
1 972
1 154
1 862
2 450
Long-Term Debt
27
483
251
0
0
452
Deferred Income Tax
3
3
3
4
12
11
Minority Interest
1 344
1
1
0
1
5
Other Liabilities
29
84
8
10
14
12
Total Liabilities
3 119
N/A
2 143
-31%
2 234
+4%
1 167
-48%
1 888
+62%
2 930
+55%
Equity
Common Stock
76
475
475
559
559
559
Retained Earnings
1 151
1 095
1 753
2 180
2 989
3 266
Additional Paid In Capital
21
1 047
1 047
3 607
3 607
3 607
Total Equity
1 248
N/A
2 617
+110%
3 275
+25%
6 346
+94%
7 155
+13%
7 432
+4%
Total Liabilities & Equity
4 367
N/A
4 759
+9%
5 509
+16%
7 513
+36%
9 043
+20%
10 362
+15%
Shares Outstanding
Common Shares Outstanding
559
559
559
559
559
559

See Also

Discover More